Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Filings indexed 568 across all filing types
Latest filing 2021-12-23 Governance Information
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
对外担保管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for external guarantees issued by the company, including procedures, responsibilities, and approval processes. It is a corporate governance-related document outlining internal control policies rather than a financial report or announcement. There is no indication of financial statements, audit results, earnings data, or shareholder meeting materials. It is not a report publication announcement or a certification. The content fits best under Governance Information (CGR) as it details company internal rules and governance practices related to external guarantees.
2021-12-23 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled "股东大会议事规则" which translates to "Shareholders' Meeting Rules" or "Rules of Procedure for the Shareholders' Meeting." It details the procedures, rules, and regulations governing the convening, proposal submission, voting, and conduct of shareholders' meetings. It includes sections on the rights and responsibilities of shareholders, board of directors, and supervisory board in relation to shareholders' meetings. There is no financial data, earnings information, or report content. It is not an announcement of voting results or a proxy solicitation but rather a governance document outlining internal rules and procedures for shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed governance rules, supporting this classification with high confidence.
2021-12-23 Chinese
独立董事关于第二届董事会第十三次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 13th meeting of the second board of directors of Huizhou Jin Hao Medical Technology Co., Ltd. It includes independent opinions on asset reclassification and related party transactions. The content focuses on board meeting matters and independent director opinions rather than financial results, audit reports, or shareholder voting results. It does not contain financial statements or earnings data, nor is it a notice of voting results or a proxy statement. It is a board/management related announcement concerning governance and internal board matters. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and specific to board opinions, not a full report or announcement of a report publication.
2021-12-23 Chinese
关于召开2022年第一次临时股东大会通知公告(提供网络投票)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice announcing the convening of the 2022 first extraordinary general meeting of shareholders (临时股东大会) for Huizhou Jin Hao Medical Technology Co., Ltd. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed, legal compliance, and registration procedures. The document does not contain financial statements or results but is focused on informing shareholders about the meeting and the matters to be voted on. It is not a report itself but a formal announcement of a shareholders meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself rather than solicitation materials or voting results, it is best classified as a Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it is not merely announcing a report publication, so RPA is not appropriate. Hence, the classification is PSI with high confidence.
2021-12-23 Chinese
独立董事工作规则
Governance Information Classification · 95% confidence The document is titled "独立董事工作规则" which translates to "Independent Director Work Rules." It details the rules, qualifications, duties, and procedures related to independent directors of the company. It references relevant laws, regulations, and governance practices, including the company's articles of association and stock exchange rules. The content is focused on governance structure and internal rules for board members rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial data, audit reports, voting results, or announcements of report publications. The document is a governance-related policy document outlining internal rules and procedures for independent directors, which fits the definition of Governance Information (CGR). The document length (7019 characters) and detailed content support it being a full governance report rather than a brief announcement or regulatory filing.
2021-12-23 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors." It details the internal rules, procedures, and governance practices for the company's board meetings, including meeting convocations, voting procedures, quorum requirements, and responsibilities of board members and the board secretary. There is no financial data, audit information, or report publication mentioned. The content is focused on governance structure and board operations. Therefore, this document fits the category of Governance Information (CGR). The document length (6672 characters) supports it being a full governance document rather than a brief announcement or notice.
2021-12-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.